BioCardia (BCDA) Asset Utilization Ratio (2011 - 2025)
BioCardia's (BCDA) quarterly Asset Utilization Ratio came in at 0.0 in Q1 2025, down 99.38% year-over-year from 0.17 in Q1 2024, and down 91.23% quarter-over-quarter from 0.01 in Q4 2024.
Analysis
BioCardia (BCDA) Asset Utilization Ratio (2011 - 2025) Analysis & Trends
BioCardia (BCDA) has reported Asset Utilization Ratio for 12 consecutive years, with 0.0 the latest figure, recorded in Q1 2025.
- On a quarterly basis, Asset Utilization Ratio fell 99.38% year-over-year to 0.0 in Q1 2025; TTM through Mar 2025 was 0.0, a 99.38% decrease from a year earlier, with the FY2024 full-year figure at 0.02, down 76.84% from the prior year.
- Asset Utilization Ratio was 0.0 for Q1 2025 at BioCardia, down from 0.01 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.17 in Q1 2024 and troughed at 0.0 in Q1 2025.
- A 5-year average of 0.09 and a median of 0.07 in 2022 frame the typical range for Asset Utilization Ratio.
- Across the five-year window, Asset Utilization Ratio jumped 1690.79% in 2022 and tumbled 99.38% in 2025, its largest moves.
- Over 5 years, Asset Utilization Ratio stood at 0.06 in 2021, then jumped by 132.03% to 0.14 in 2022, then slipped by 0.6% to 0.14 in 2023, then slumped by 91.8% to 0.01 in 2024, then tumbled by 91.23% to 0.0 in 2025.
- The last three Asset Utilization Ratio figures came in at 0.0 (Q1 2025), 0.01 (Q4 2024), and 0.02 (Q3 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 0.30 |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | 0.00 |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 0.35 |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 0.76 |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | 0.02 |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | 0.11 |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 0.55 |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | 0.62 |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 0.62 |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | 0.15 |
| Mar 31, 2024 | 0.17 |
| Dec 31, 2023 | 0.14 |
| Sep 30, 2023 | 0.11 |
| Jun 30, 2023 | 0.06 |
| Mar 31, 2023 | 0.16 |
| Dec 31, 2022 | 0.14 |
| Sep 30, 2022 | 0.13 |
| Jun 30, 2022 | 0.16 |
| Mar 31, 2022 | 0.07 |
| Dec 31, 2021 | 0.06 |
| Sep 30, 2021 | 0.05 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | 0.01 |
| Dec 31, 2020 | 0.01 |
| Sep 30, 2020 | 0.03 |
| Jun 30, 2020 | 0.05 |